Montag & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87K | Hold |
34
| – | – | ﹤0.01% | 849 |
|
|
2025
Q1 | $2.4K | Hold |
34
| – | – | ﹤0.01% | 880 |
|
|
2024
Q4 | $2.24K | Hold |
34
| – | – | ﹤0.01% | 882 |
|
|
2024
Q3 | $2.39K | Hold |
34
| – | – | ﹤0.01% | 905 |
|
|
2024
Q2 | $2.8K | Hold |
34
| – | – | ﹤0.01% | 856 |
|
|
2024
Q1 | $2.97K | Hold |
34
| – | – | ﹤0.01% | 847 |
|
|
2023
Q4 | $3.28K | Hold |
34
| – | – | ﹤0.01% | 846 |
|
|
2023
Q3 | $3.01K | Hold |
34
| – | – | ﹤0.01% | 828 |
|
|
2023
Q2 | $2.95K | Hold |
34
| – | – | ﹤0.01% | 842 |
|
|
2023
Q1 | $3.31K | Hold |
34
| – | – | ﹤0.01% | 839 |
|
|
2022
Q4 | $3.52K | Hold |
34
| – | – | ﹤0.01% | 844 |
|
|
2022
Q3 | $3K | Hold |
34
| – | – | ﹤0.01% | 799 |
|
|
2022
Q2 | $3K | Hold |
34
| – | – | ﹤0.01% | 758 |
|
|
2022
Q1 | $3K | Hold |
34
| – | – | ﹤0.01% | 769 |
|
|
2021
Q4 | $3K | Hold |
34
| – | – | ﹤0.01% | 780 |
|
|
2021
Q3 | $3K | Hold |
34
| – | – | ﹤0.01% | 776 |
|
|
2021
Q2 | $3K | Hold |
34
| – | – | ﹤0.01% | 770 |
|
|
2021
Q1 | $3K | Hold |
34
| – | – | ﹤0.01% | 775 |
|
|
2020
Q4 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 756 |
|